Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAferian Regulatory News (AFRN)

  • This share is currently suspended. It was suspended at a price of 0.55
  • There is currently no data for AFRN

Director/PDMR Shareholding

18 Sep 2023 07:00

RNS Number : 6832M
Aferian PLC
18 September 2023
 

18 September 2023

 

Aferian plc

Directors' Dealings

Aferian plc (LSE:AFRN, "Company" or "AFRN") received notification on the 15 September 2023 from Kestrel Partners LLP ("Kestrel") that on the 15 September 2023 it purchased, on behalf of its discretionary client accounts, an aggregate of 125,000 ordinary shares of 1p each ("Shares") in the Company at an average price of 16.7 pence per share.

Mr Royde is a partner of, and holds a beneficial interest in, Kestrel. Mr Royde is also a shareholder in Kestrel Opportunities and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in AFRN.

Following this transaction, Kestrel Opportunities holds (and consequently Mr Royde is deemed to have a beneficial interest in) 16,784,114 Shares in the Company, and other clients of Kestrel, in which Mr Royde has no beneficial interest hold 12,067,622 Shares in the Company.

On a combined basis, Kestrel indirectly holds voting rights over 28,851,736 Shares in the Company, which represents 25.94 per cent of the total voting rights in the Company.

Kestrel's interest in the Shares in the Company is held through the following nominees:

Holding type

Nominee

No. of shares

% of total voting rights

Indirect

Bank of New York Nominees Ltd

16,784,114

15.09%

Indirect

JIM Nominees Limited

756,163

0.68%

Indirect

Bank of New York Nominees Ltd

7,463,390

6.71%

Indirect

Northern Trust Company AVFC

3,848,069

3.46%

 

For further information contact:

 

Aferian Plc

Donald McGarva, Chief Executive Officer

Mark Carlisle, Chief Financial Officer

 +44 (0) 1223 598197

 

 

Investec (NOMAD and Broker)

David Anderson / Patrick Robb / Nick Prowting / Cameron MacRitchie

 

+44 (0) 20 7597 5970

 

FTI Consulting LLP (Financial Communications)

Matt Dixon / Emma Hall / Tom Blundell / Aisha Hamilton

+44 (0) 203 3727 1000

 

 

 

 

 

 

 

 

ANNEX

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Kestrel Partners LLP

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PCA - Max Royde (non-executive director Aferian plc)

b)

 

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Aferian plc

b)

 

LEI

 

21380068JIMBNNZJL315

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Identification code

 

Ordinary shares of 1p each 

 

ISIN: GB00B013SN63

 

b)

 

Nature of the transaction

 

 Purchase

c)

 

Price(s) and volume(s)

 

Transfer

 

Purchase

 

Purchase

15 September 2023

Price(s)

 

Volume(s)

16.7 pence

125,000 shares

d)

 

Aggregated information

- Aggregated volume

- Price

 

Purchase Total 125,000 shares at an average price of 16.7 pence.

e)

 

Date of the transaction

 

15 September 2023

f)

 

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDZGMLVNNGFZM
Date   Source Headline
1st Oct 20251:04 pmRNSForm 8.3 - Aferian plc
30th Sep 20252:57 pmRNSForm 8.3 - Aferian plc
30th Sep 20252:19 pmRNSForm 8.3 - Aferian plc
30th Sep 20251:51 pmEQSForm 8.3 - Apex Fundrock Limited : Aferian PLC
29th Sep 20251:47 pmPRNForm 8.3 - Aferian plc
29th Sep 202511:17 amRNSHolding(s) in Company
29th Sep 202510:04 amRNSExtension to banking facilities and sale process
24th Sep 20255:42 pmRNSHolding(s) in Company
26th Aug 20259:19 amRNSHolding(s) in Company
18th Aug 20259:16 amRNSNotification of Major Holdings
28th Jul 20257:00 amRNSHalf-Year Results
23rd Jun 20257:00 amRNSTrading Update
22nd May 20253:30 pmRNSResult of AGM
23rd Apr 20257:00 amRNSNotice of AGM
10th Apr 20257:00 amRNSFull Year Results
11th Dec 20247:00 amRNSTrading Update and Change of Adviser
2nd Dec 20247:00 amRNSDirectorate Change
6th Nov 20241:41 pmRNSDirector/PDMR Shareholding
5th Nov 20247:00 amRNSTrading Statement
26th Sep 20245:40 pmRNSGrant of Share Options
1st Aug 20247:00 amRNSHalf-Year Results
3rd Jul 20247:00 amRNSNon-Executive Board Changes
3rd Jul 20247:00 amRNSExecutive Board and Senior Management Changes
28th Jun 202411:46 amRNSResult of General Meeting
7th Jun 20247:00 amRNSHolding(s) in Company
6th Jun 20243:47 pmRNSHolding(s) in Company
6th Jun 20247:00 amRNSNotice of AGM
31st May 202410:11 amRNSFull Year Results - Replacement
31st May 20247:00 amRNSFull Year Results
30th May 20244:29 pmRNSResult of AGM
7th May 20247:00 amRNSNotice of AGM
7th May 20247:00 amRNSExtended Finance Facilities
22nd Apr 20247:00 amRNSBoard Change
22nd Apr 20247:00 amRNSTrading Update
11th Jan 20247:00 amRNSShare Options
5th Dec 20237:00 amRNSTrading Statement
29th Nov 20234:58 pmRNSHolding(s) in Company
18th Sep 20237:00 amRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNS24i and Amino to power video services for Thurcom
4th Sep 20237:00 amRNSDirector/PDMR Shareholding
31st Aug 20232:53 pmRNSDirector/PDMR Shareholding
31st Aug 20237:01 amRNSAppointment of Non-Executive Director
31st Aug 20237:00 amRNSHalf-year Results
29th Aug 20234:49 pmRNSNotice of Results
23rd Aug 20237:00 amRNS24i and Amagi power new Virgin Media FAST channels
26th Jul 20233:16 pmRNSHolding(s) in Company
26th Jul 202310:39 amRNSAferian Director/PDMR Shareholding
25th Jul 20237:00 amRNSResults of Placing & PDMR Dealings
24th Jul 20234:35 pmRNSProposed Placing to raise up to US$4.0m
28th Jun 20237:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.